Novo Nordisk is well-positioned in the obesity drug market, with strong financials and anticipation for its oral Wegovy pill.

Concrete already builds our world, and now it's one step closer to powering it, too. Made by combining cement, water, ...

VistaShares Target 15 Berkshire Select Income ETF blends Buffett-style investing with a 15% annual income target via covered ...

Wesco Distribution’s automation lead Max Ioffe has built a program where the business owns the bots — not the other way ...

In this week's, Dr. David Gordon examines John Tomasi's thesis of Free Market Fairness that the collectivism espoused by John ...

Jakob Sanderson crunches the numbers to provide a fantasy football player valuation guide for those looking to shop in the ...

Keshav Agarwal of Daylight Capital explains the kind of support D2C brands need today to navigate decisions around branding, ...

Discover how adaptable lighting transforms modern architecture—delivering modular infrastructure, tunable spectrum, and ...

BlackSoil Capital, the NBFC arm of BlackSoil Group, successfully raised ₹210 crore in debt during the first half of the ...

Founded in 2005, Dehradun-based Planet Herbs Lifesciences herbal and nutraceutical company specialising in natural medicines ...

Kinross Gold (NYSE: KGC) has surged above a 12-year resistance level in its ratio against gold, breaking a long period of ...

A paper published a few years ago in the American Economic Journal has raised eyebrows within and outside of the profession.